TGFB1 and breast carcinoma: Further advancing this finding, we devised a DMA‐based therapeutic approach that hindered the communication between CAFs and breast cancer cells to reduce TGF‐β signalling levels in breast cancer cells at the primary tumour and impair multiorgan metastasis.